Synaps Dx

About:

Synaps Dx focuses on the research, development and commercialization for neurodegenerative disorders including Alzheimer’s Disease.

Website: https://www.synapsdx.com

Twitter/X: getdiscern

Top Investors: Semler Scientific, Bull & Bear

Description:

Synaps Dx is a privately held company focused on the research, development, and commercialization of diagnostics for neurodegenerative disorders and conditions, including Alzheimer’s Disease.

Total Funding Amount:

$10M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Rockville, Maryland, United States

Founded Date:

2016-01-01

Contact Email:

info(AT)synapsdx.com

Founders:

Paul Tanico

Number of Employees:

1-10

Last Funding Date:

2022-03-02

IPO Status:

Private

Industries: